In Parkinson’s disease, leucine-rich repeat kinase 2 (LRRK2) also promote the expression of transcriptional factors E2F1 by downregulating the expression of miR-184 and let-7 (148). This evidence concerns the gene LRRK2 and Parkinson disease.